SPOTLIGHT -
Associate Professor of Clinical Neurology, University of Colorado
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?
Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
From “Diagnose and Adiós” to Brain Health: Are We There Yet?
Since the days of limited treatment in neurology, 30 years of progress have brought an expanded armamentarium of therapies for many neurological disorders.
Prioritizing Brain Health in Multiple Sclerosis: Augusto Miravalle, MD
The neurologist at the University of Colorado offered an overview of the State of the Science Summit that was held on August 18, 2022, featuring a panel of expert clinicians. [WATCH TIME: 5 minutes]
Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS
The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.
